Papers
1
Total Citations
7
H-Index
1
About
Dr. Shan Yin is a leading urological surgeon whose research centers on minimally invasive surgical oncology, with a particular focus on robot-assisted techniques for renal cancer treatment. His major contributions include pioneering evidence that robot-assisted laparoscopic partial nephrectomy (RAPN) is equally effective and safe for both cystic and solid renal masses, challenging previous clinical assumptions that favored different approaches. His landmark 2023 meta-analysis, which systematically reviewed controlled trials from major databases including Cochrane and PubMed, demonstrated comparable perioperative and oncological outcomes between these tumor types, providing crucial guidance for surgical decision-making. This work has already garnered 7 citations, establishing Dr. Yin as an emerging authority in robotic urologic surgery. By synthesizing data from multiple international studies, he has helped standardize surgical protocols and expand the indications for nephron-sparing surgery. His research bridges the gap between technological innovation and clinical practice, offering urologists evidence-based confidence in treating complex renal tumors. Dr. Yin’s work continues to shape the evolution of robotic surgery, making him a valuable resource for surgeons and researchers seeking to optimize outcomes in renal cell carcinoma management.
Research Focus
Key Achievements
Top Papers
- 1